Vaccines are already available in Australia and New Zealand, and they are being tested for their effectiveness.
But there’s a huge caveat: They can’t cure every disease.
So what can we expect in Australia?
Here are four possible scenarios: A vaccine against CJD that can be given at home to anyone with a history of CJD, and who has a positive result.
In this scenario, all patients will receive the same shot.
There is no risk of the virus spreading to others.
A vaccine for CJD but against the virus itself.
This scenario would be especially effective, because the virus is still circulating in Australia, and people who have been exposed to it are more likely to catch it.
A vaccination for those who have had the disease but not all who are susceptible.
This is likely to be the most effective.
The vaccine would only be given to people with a positive reaction, so it would have a limited effectiveness.
This would be the worst of the possible outcomes, as it would leave some people with very severe symptoms but no chance of infection.
A combination of both, such as one shot given at a hospital for people with severe symptoms, followed by a second shot at home.
In these scenarios, the vaccines would be given both at home and at a private clinic.
The first shot would be administered after an initial test, which would identify whether the person was at risk for the disease.
The second shot would then be given within 24 hours of symptoms starting, with the vaccine administered as a second dose on the second day.
The third shot would follow 24 hours later, after the first dose had been administered.
The fourth shot would also be given after symptoms had started to settle down, and the second dose would be followed 24 hours after that.
In all cases, people with the disease would receive both shots, and those who had not yet developed the symptoms would receive a third shot, but they would be at higher risk of developing serious complications, including severe fever, pneumonia and death.
If all of the above vaccines are successful, Australia will see an annualised reduction of more than 2 per cent in the number of people living with the virus, with a decrease of almost 12 per cent for the country’s elderly and those with other serious health conditions.
The hope is that these vaccines will reduce the virus’s spread to those who are most susceptible to infection.
But if the vaccine proves ineffective, Australia would face a devastating pandemic.
That would mean a massive drop in the country, with more than 100,000 deaths a year and millions of people losing their jobs.
What can be done to protect the country?
Australia is one of the world’s most developed countries, and it has a relatively low rate of mortality from the coronavirus.
But the virus has a far more damaging impact on people than on animals, which is why we’ve been trying to protect people from it by vaccinating them.
We have some successful vaccines that are currently being tested, but there’s also a range of vaccine alternatives.
Some have shown promising results, but not everyone has been convinced.
Others have been given little or no testing, which means they are still unknown.
So it’s not clear whether a vaccine is likely ever to be developed.
But a number of different organisations, including the World Health Organization and the US Centers for Disease Control and Prevention, are working on developing vaccines.
The Australian Government is funding research on vaccine alternatives, including a vaccine that could be given by mail to those without symptoms, and one that is also being tested in the US.
This new vaccine could also be tested in Europe, although the European vaccine trials are currently running behind schedule, with just three trials being completed.
Australia has been involved in trials of vaccines against diphtheria and tetanus, and we are also looking at how to develop a vaccine for the flu.
But it’s too early to tell if Australia will be able to provide a safe vaccine that can treat people living in Australia.
This article was originally published on New Scientist.